Protein S-nitrosylation has emerged as a principal mechanism by which nitric oxide exerts biological effects. Among methods for studying protein S-nitrosylation, the biotin switch technique (BST) has rapidly gained popularity because of the ease with which it can detect individual S-nitrosylated (SNO) proteins in biological samples. The identification of SNO sites by the BST relies on the ability of ascorbate to generate a thiol from an S-nitrosothiol, but not from alternatively S-oxidized thiols (e.g. disulfides, sulfenic acids). However, the specificity of this reaction has recently been challenged, prompting several claims that the BST may produce false-positive results and raising concerns about the application of the BST under oxidizing conditions. Here we perform a comparative analysis of the BST using differentially S-oxidized and S-nitrosylated forms of protein tyrosine phosphatase 1B, as well as intact and lysed human embryonic kidney 293 cells treated with S-oxidizing and S-nitrosylating agents, and verify that the assay is highly specific for SNO. Strikingly, exposure of samples to indirect sunlight from a laboratory window resulted in artifactual ascorbate-dependent signals that are likely promoted by the semidehydroascorbate radical; protection from sunlight eliminated the artifact. In contrast, exposure of SNO proteins to a strong ultraviolet light source (SNO photolysis) prior to the BST provided independent verification of assay specificity. By combining BST with photolysis, we have shown that anti-cancer drug-induced oxidative stress facilitates the S-nitrosylation of the major apoptotic effector glyceraldehyde-3-phosphate dehydrogenase. Collectively, these experiments demonstrate that SNO-dependent signaling pathways can be modulated by oxidative conditions and suggest a potential role for S-nitrosylation in antineoplastic drug action.
Nitric oxide (NO)
2 executes a diverse range of cellular functions through the redox-dependent conversion of protein Cys thiols to S-nitrosothiols (SNOs). This post-translational modification, known as S-nitrosylation, has emerged as a highly conserved and spatiotemporally specific signaling mechanism (1) . A major contribution to this field was the introduction of the biotin switch technique (BST) by Jaffrey et al. in 2001 (2) . Importantly, the BST allows relatively facile identification and quantification of endogenous protein SNOs and thus has greatly contributed to our understanding of protein S-nitrosylation. As evidence, the BST has been employed in over 70 publications, unveiling new roles for S-nitrosylation in events such as apoptosis (3) , neurodegeneration (4, 5) , insulin signaling (6, 7) , and receptor trafficking (8) .
The BST consists of three principal steps (supplemental Fig.  S1 ): "blocking" of free Cys thiols by S-methylthiolation with S-methyl methanethiosulfonate (a reactive thiosulfonate), formal reduction of SNOs to thiols with ascorbate (Asc), and in situ "labeling" by S-biotinylation of the nascent thiols with biotin-HPDP, a reactive mixed disulfide. The degree of biotinylation (and hence S-nitrosylation) is determined by either antibiotin immunoblotting or streptavidin pull down followed by immunoblotting for the protein(s) of interest. Complete blocking of free thiols is requisite for minimizing background biotinylation (i.e. improving signal-to-noise or sensitivity), while the specificity of the BST is predicated on the ability of Asc to reduce SNOs to free thiol, without reducing other Cys-based redox modifications such as S-glutathionylation or S-oxidations (sulfenic, sulfinic, and sulfonic acids). Importantly, transition metal-catalyzed reactions, particularly those that might limit the specificity of Asc, are mitigated through use of metal chelators (e.g. EDTA, DTPA, neocuproine).
Despite the unequivocal ability of the BST to detect SNOs, the specificity of Asc for SNO reduction has not been extensively investigated. Landino et al. (9) suggested that Asc reduces tubulin disulfides, a claim the authors use to challenge the validity of the BST. Furthermore, two other groups have reported that S-glutathionylated proteins yield positive signals in this assay (10, 11) . A more recent report by Huang et al. (12) argued that the BST yields "artifactual" Asc-dependent biotinylation of native reduced bovine serum albumin. They extrapolate this finding to argue that the BST may result in false-positive (i.e. SNO-independent) biotinylation, which could cast doubt upon the myriad of studies that have relied heavily on this assay.
Shared between these claims of artifactual signals is the idea that Asc must be reducing disulfides (S-glutathionylated or intramolecular disulfides). However, this notion is difficult to reconcile experimentally with the use of S-methyl methanethiosulfonate as a blocking agent (i.e. protein thiols are S-methylthiolated to form mixed disulfides). The assay would never work if ascorbate removed the blocking agent, and in fact, the two e Ϫ reduction of Cys disulfides to thiol (Cys thiol/disulfide E red Ϫ170 to Ϫ320 mV) by Asc is highly thermodynamically unfavorable (Asc/DHAsc E red ϩ70 mV) (13) . Thus, one would not expect Asc to directly reduce any biological Cys oxidation products. Instead, the electrochemical measurements favor the reverse reaction (i.e. thiol-dependent reduction of dehydroascorbate (DHAsc0 to Asc), a scenario supported by extensive observations (14, 15) .
Despite the thermodynamic and empiric evidence against Asc-dependent disulfide reduction (and alternative interpretations for some of the prior results that have formed the basis of challenge to the BST), we felt it was important to evaluate the specificity of the BST and the sources of potential artifacts. Further, we sought to employ the BST to differentiate S-nitrosylated from S-oxidized proteins under conditions of diverse oxidative and nitrosative stresses, as such analyses have not been previously possible.
EXPERIMENTAL PROCEDURES
Materials-All materials were from Sigma unless otherwise indicated. Anti-biotin, anti-pentaHis, anti-glutathione (anti-GSH), anti-PTP1B, and anti-glyceraldehyde-3-phosphate dehydrogenase (anti-GAPDH) monoclonal antibodies were from Vector Laboratories, Qiagen, Virogen, BD Biosciences, and Chemicon, respectively. Nickel-nitrilotriacetic acid resin was from Qiagen. The cDNA sequence encoding the N-terminal 321 residues of PTP1B in pET14b was a kind gift from S. G. Rhee (National Institutes of Health). CysNO was freshly synthesized by mixing equimolar volumes of L-Cys in 0.5 M HCl and NaNO 2 . BCNU was freshly prepared as a 50-mM stock in EtOH and used immediately.
Cell Culture and Treatments-Wild-type or stably expressing neuronal nitric-oxide synthase (nNOS) HEK-293 cells (16) were cultured in Dulbecco's modified essential medium supplemented with 10% fetal bovine serum and treated with indicated agents at ϳ90% confluency. Cells were washed and collected with cold phosphate-buffered saline followed by lysis in HEK lysis buffer (25 mM HEPES, 50 mM NaCl, 0.1 mM EDTA, 0.1 mM neocuproine, 0.1% Nonidet P-40, 1 mM phenylmethylsulfonyl fluoride).
Purification and Characterization of PTP1B-A 1-liter culture of BL21 Escherichia coli harboring pET14b-PTP1B at A 600 ϭ 1.0 was induced with 1 mM isopropyl-1-thio-␤-D-galactopyranoside for 4 h at 37°C followed by purification of PTP1B with nickel-nitrilotriacetic acid resin as described by Qiagen. The purified protein (4.5 mg/ml) was treated with 10 mM dithiothreitol (DTT) for 30 min followed by buffer exchange with Bio-Gel P-6DG (Bio-Rad) equilibrated in HEN buffer (250 mM HEPES, 1 mM EDTA, 0.1 mM neocuproine, pH 7.7). For measurement of phosphatase activity, PTP1B was diluted to 2.5 g/ml with phosphatase assay buffer (100 mM Tris, 2 mM EDTA, 5 mM p-nitrophenyl phosphate, pH 8.0) and optical absorbance was measured continuously at 405 nm. PTP1B S-glutathionylation was assessed by immunoblotting with anti-GSH antibody (1:1000). PTP1B S-nitrosylation was confirmed using the Saville assay. Samples were mixed with one volume of 1% sulfanilamide with 2 mM HgCl 2 in 1 M HCl for 5 min followed by addition of one volume of 0.05% N-(1-napthyl)ethylenediamine in 0.5 M HCl, and absorbance was read at 540 nm.
Protein Modifications and Biotin Switch Technique-Proteins/lysates were treated with the indicated concentrations of H 2 O 2 , diamide, glutathione disulfide (GSSG), or CysNO followed by desalting with Bio-Gel P-6DG. The BST was performed on purified PTP1B as described (17) and with several modifications as follows.
Samples were mixed with 2 volumes of HEN buffer followed by addition of freshly prepared S-methyl methanethiosulfonate (10% v/v in N,N-dimethylformamide) and SDS (25% v/v) to final concentrations of 0.1 and 2.5%, respectively. Following frequent vortexing at 50°C for 20 min, proteins were precipitated with 3 volumes of acetone at Ϫ20°C for 15 min. The proteins were recovered by centrifugation at 5,000 ϫ g for 5 min, followed by gentle rinsing of the pellet with 4 ϫ 1 ml 70% acetone/H 2 O. The pellets were then resuspended in 240 l of HEN buffer containing 1% SDS. For labeling, the blocked samples were mixed with 0.1 volume of biotin-HPDP (2.5 mg/ml in Me 2 SO) and 0.1 volume of HEN (control) or freshly prepared sodium Asc in HEN buffer. Labeling reactions were performed in the dark at room temperature for 1 h unless otherwise indicated. Indirect sunlight was introduced by incubating the labeling reactions near a laboratory window without direct exposure to sunlight or change in temperature.
For direct detection of protein biotinylation, 20 -40 g of each labeling reaction was resolved by non-reducing SDS-PAGE, followed by immunoblotting with anti-biotin antibody (1:500). To detect an individual SNO protein from cells or lysates, the labeling reaction was acetone-precipitated as previously described. The washed pellet was resuspended in 250 l of HEN/10 (HEN diluted 10-fold into H 2 O) containing 1% SDS, followed by addition of 750 l of neutralization buffer (25 mM HEPES, 100 mM NaCl, 1 mM ETDA, 1% Triton X-100, pH 7.5). This material was incubated overnight at 4°C with 40 l of a streptavidin-agarose slurry. The beads were washed with 4 ϫ 1 ml of wash buffer (neutralization buffer ϩ 500 mM NaCl), followed by 2 ϫ 1 ml of neutralization buffer. The dried beads were eluted with 50 l of HEN/10 ϩ 1% ␤-mercaptoethanol at room temperature for 20 min. The eluted mixture was then analyzed by SDS-PAGE, followed by immunoblotting with anti-PTP1B (1:1000) or anti-GAPDH (1:1000) antibodies.
Thiol Measurements and GSSG Reductase Activity AssaysThiols were assayed by addition of one volume of 0.1 mg/ml 5,5Ј-dithiobis(2-nitrobenzoic acid) in HEN. Absorbances of samples and GSH standards were immediately read at 405 nm. Activity of GSSG reductase was measured as described (18) by following GSSG-dependent consumption of NADPH at 340 nm.
SNO Photolysis-Lysates or purified proteins were incubated in a Pyrex borosilicate NMR tube ϳ2 cm from a 200-watt mercury vapor lamp (Hanovia) for 3 min, which provides ϳ4 watts of radiation from ϳ280 -500 nm. During this time, the sample temperature was unchanged. Immediately following this incubation, the samples were subjected to the BST as described.
RESULTS

Specificity of the Biotin Switch Technique for the Detection of
Protein S-Nitrosothiols-To evaluate the specificity of the BST, we first sought to perform the assay with an exemplary protein on which we could introduce alternative Cys modifications, including free sulfhydryl (-SH), S-glutathionyl mixed disulfide (-SSG), sulfenic/sulfinic/sulfonic acids (-SOH, -SO 2 H, -SO 3 H), and S-nitrosothiol (-SNO). Human protein tyrosine phosphatase 1B (PTP1B), with its well characterized redox-regulated active site Cys residue (19) , satisfied these criteria. Treatment of reduced PTP1B with H 2 O 2 resulted in the partially DTT-reversible inhibition of enzyme activity suggestive of a mixture of -SOH/sulfenyl amide (reversible) and -SO 2 H/-SO 3 H (irreversible) modifications (Fig. 1A) . Incubation of PTP1B with oxidized glutathione (GSSG) or S-nitrosocysteine (CysNO) resulted in S-glutathionylation (Fig. 1B) or S-nitrosylation (Fig.  1C) , respectively. Reduced and redox-modified PTP1Bs were then subjected to the BST with various concentrations of Asc. Under these conditions, only the S-nitrosylated PTP1B was biotinylated (Fig. 1D) . It should be noted that even with 100 mM Asc, the assay specificity was not compromised. The use of 100 mM Asc did not, however, improve sensitivity (i.e. result in increased biotinylation of SNO-PTP1B) relative to 10 mM Asc, suggesting that under these conditions the reaction with Asc is not a limiting factor.
To investigate the specificity of the assay in situ, and in particular to determine whether any cellular components might limit the specificity of the assay, we subjected H 2 O 2 -, GSSG-, and CysNO-treated lysates from HEK-293 cells to the BST and assayed for the biotinylation of endogenous PTP1B by streptavidin pull down and immunoblotting (Fig. 1E) . As with purified PTP1B, biotinylation was observed only in the CysNO-treated samples, but in this case the labeling of PTP1B was higher at 100 mM than 10 mM Asc. This can be well rationalized: because the reaction rates for transnitrosylation between SNOs and ascorbate vary over three orders of magnitude and are first order for each reactant (20) , low abundance protein SNOs may require larger Asc concentrations to facilitate this reaction. Another possibility is that Asc is consumed by oxidants present in the cellular extracts. Thus, whereas 1 mM Asc is sufficient for detection of some S-nitrosylated proteins as originally described (2), the general sensitivity of the assay may be enhanced by the use of higher Asc concentrations.
To more generally assess assay specificity, we examined biotinylation by the BST of multiple S-nitrosylated, S-oxidized, or S-glutathionylated cellular proteins. HEK-293 cell lysates or intact cells were treated with CysNO, H 2 O 2 , and either GSSG FIGURE 1. Specificity of the BST in vitro and in situ: analysis of PTP1B. PTP1B (4.5 mg/ml) was treated with 0.2 mM H 2 O 2 , 0.2 mM CysNO, or 10 mM GSSG in HEN buffer, chemically characterized, and subjected to the BST. A,H 2 O 2 -treated PTP1B was incubated in phosphatase assay buffer, and optical absorbance at 405 nm was recorded. B, GSSG-treated PTP1B was analyzed by anti-GSH immunoblot. C, CysNO-treated PTP1B was subjected to the Saville assay, and optical absorbance at 540 nm was recorded. D, each oxidatively modified or S-nitrosylated PTP1B (50 g) was subjected to the BST with 0, 10, and 100 mM Asc. E, HEK-293 lysates (0.5 mg each) were treated with 0.5 mM H 2 O 2 , 10 mM GSSG, or 0.5 mM CysNO and subjected to the BST. Biotinylated PTP1B was detected by streptavidin pulldown and anti-PTP1B immunoblotting. (lysates) or diamide, a thiol-oxidizing agent (intact cells), and then analyzed by the BST. Under these conditions, protein biotinylation was strictly dependent upon treatment with CysNO and the inclusion of Asc during the labeling step (Fig.  2, A and B) . To complement these results, we also showed that S-glutathionylated proteins were not reduced in the BST (Fig. 2C) .
Conditions That Promote S-Nitrosothiol-independent Protein Biotinylation-Although the BST appeared to be highly specific for protein SNOs under our assay conditions, we nonetheless sought to investigate the recent claim of artifactual Asc-dependent biotinylation of reduced bovine serum albumin (12) . We reasoned that this SNO-independent, Asc-dependent protein biotinylation must involve reduction of protein disulfides (including S-methythiolated cysteines) or biotin-HPDP. Ultraviolet radiation is known to facilitate the indirect reduction of protein disulfides (21, 22) as well as the one e Ϫ oxidation of Asc to the reactive semi-DHAsc radical, which can reduce nonbiological (reactive) aryl disulfides such as 4,4Ј-dithiopyridine (23) . We further reasoned that Asc would rapidly reduce protein thiyl radicals (24) generated by UV radiation, providing thiol substrate for biotinylation. Accordingly, we sought to determine whether light could promote artifactual biotinylation during the labeling step of the BST (the assay as originally described was performed in the dark).
Interestingly, pre-reduced bovine serum albumin, lactoglobulin, and GAPDH were biotinylated when the labeling reactions were exposed to indirect sunlight, but not when kept in the dark, even after a 16-h incubation (standard incubations are 1-2 h) (Fig. 3A) . Similar results were seen without DTT pre-reduction (data not shown). Further, artifactual biotinylation was fully reversed by excess DTT (Fig. 3C) , confirming that the biotin was attached to the protein via a disulfide bond. In addition, the samples exposed to sunlight exhibited a marked yellowing indicative of Asc oxidation to DHAsc, whereas those kept in the dark remained essentially colorless.
To determine the effects of this artifact under typical laboratory conditions, we performed the BST on reduced and S-nitrosylated GAPDH and exposed the labeling reactions to either fluorescent lighting (in a windowless room) or indirect sunlight (a laboratory bench ϳ2 meters from a window) (Fig. 3B) . Under fluorescent lighting, only SNO-GAPDH underwent Ascdependent biotinylation (Fig. 3B, lanes 1-4) ; this specific SNO signal was comparable with that obtained in the dark (not shown). In contrast, indirect sunlight led to increases in Ascdependent biotinylation of both reduced and S-nitrosylated GAPDH (lanes 5-8) . Even in the absence of Asc, indirect sunlight potentiated the biotinylation of SNO-GAPDH (lane 3 versus lane 7) , consistent with known UV sensitivity of the SNO. Furthermore, the combination of indirect sunlight and Asc dramatically increased the biotinylation of SNO-GAPDH (lane 4 versus lane 8) , notwithstanding loss of SNO specificity under these conditions.
To understand the mechanism of this artifact, we examined the ability of Asc to reduce biotin-HPDP to biotin-SH under the conditions of the BST. Interestingly, nearly quantitative reduction of biotin-HPDP occurred in the presence of Asc and indirect sunlight, but not Asc alone (Fig. 3D) . The production of high micromolar biotin-SH during the BST would lead to arti- (25) (26) (27) (28) . To complement the Asc control in instances such as these, we sought to introduce a separate method to independently confirm the existence of an SNO moiety. Because UV light will efficiently cleave (photolyze) an SNO (29), we reasoned that it should eliminate SNOs. We thus exposed SNO-GAPDH to UV radiation prior to the BST. This treatment resulted in a significant decrease in Asc-dependent biotinylation of SNO-GAPDH (Fig. 4A) . The generality and biological utility of this approach were confirmed using CysNO-treated HEK-293 cells (Fig. 4B) , which also demonstrated a strong attenuation of biotinylation when the lysates were first subjected to photolysis.
Effects of Oxidative Stresses on Protein S-Nitrosylation-Despite reports that GSH depletion (30 -32) and exogenous peroxides (33) facilitate S-nitrosylation, relatively little is known about the overall role of oxidative stimuli in modulating protein SNOs. Furthermore, such studies require methodologies that can differentiate SNOs from other cotemporaneous Cys-based redox modifications. The BST coupled with SNO photolysis would seem to be ideal for such analyses.
To this end, we examined the effects of BCNU (carmustine), a clinically employed alkylating/carbamoylating agent often used to treat astrocytomas, on general Cys redox status and S-nitrosylation. Consistent with previous reports (34, 35) , BCNU efficiently inhibited GSSG reductase in HEK-293 cells (Fig. 5A) , which has been shown to increase the cellular GSSG/ GSH ratio and thereby induce oxidative stress (36) . Furthermore, these conditions resulted in a loss of cellular protein thiols (Fig. 5B) , demonstrating the effects of BCNU on Cys redox status of both low molecular weight thiols and proteins. Next, HEK-293 cells stably expressing nNOS were treated with BCNU and subjected to the BST. A dose-dependent increase in SNO-GAPDH was observed (Fig. 5C ) that correlated with both GSSG reductase inhibition (Fig. 5A ) and protein thiol oxidation (Fig. 5B) . To confirm that modification of GAPDH by S-nitrosylation was consequent upon BCNU-induced oxidative stress (and hence to differentiate SNO from other Cys redox modifications), we employed SNO photolysis prior to the BST. As expected, UV pretreatment of samples resulted in a marked decrease in biotinylated GAPDH (Fig. 5D ).
DISCUSSION
Jaffrey and Snyder (2, 3, 37-39) have provided unequivocal demonstrations of the utility of the BST for identifying SNOs. Given the widespread use of the assay, it remains important to show that assay specificity, which has to date been examined for a limited number of proteins (2, 39) , in fact captures the general behavior of SNO proteins in complex biological systems. Here, we confirm that the BST is in fact highly selective for S-nitrosylated versus S-oxidized (sulfenic acid and disulfide) groups in proteins and that assay specificity, which is a unique feature of the chemistry between Asc and SNO, can be generalized to many classes of proteins.
Interestingly, the one e Ϫ reduction potential of GSH/GSNO is ϳϪ180 mV (40) , indicating that Asc cannot directly reduce the S-NO bond (the Asc/semi-DHAsc radical E red is ϩ280 mV) FIGURE 4 . UV photolysis prior to the BST eliminates SNO-dependent signals. A, GAPDH (5 mg/ml) was untreated or incubated with 0.5 mM CysNO. After removing excess CysNO, one sample of SNO-GAPDH was incubated for 2 min near a mercury vapor lamp. The samples (1 mg each) were then subjected to the BST in the presence or absence of 50 mM Asc, and biotinylation was measured by anti-biotin immunoblotting. B, HEK-293 cells were either untreated or incubated with 0.5 mM CysNO for 5 min, followed by lysis with or without later exposure for 3 min to a UV-visible mercury vapor lamp. The BST was performed in the presence or absence of 50 mM Asc, and biotinylation was analyzed by anti-biotin immunoblotting. FIGURE 5. S-Nitrosylation of GAPDH is promoted by BCNU-induced oxidative stress. A, wild-type HEK-293 cells were treated with BCNU for 6 h, lysed, and assayed for GSSG reductase (GR) activity. B, lysates from panel A were desalted and protein thiols quantified by 5,5Ј-dithiobis(2-nitrobenzoic acid) assay. C, HEK-293 cells stably expressing nNOS were treated with BCNU for 6 h and subjected to the BST, followed by immunoblotting for GAPDH. D, nNOS-HEK cells were either untreated or incubated for 6 h with 100 M BCNU. Lysates were either untreated or SNO-photolyzed and subjected to the BST. (41) . Yet the BST requires that Asc liberate NO from SNO, which constitutes a formal one e Ϫ reduction. The solution to this paradox is to understand that Asc does not directly donate an electron to SNO but rather undergoes transnitrosation by SNO (a bimolecular reaction involving NO ϩ transfer) to generate O-nitrosoascorbate, which rapidly homolyzes to yield the semi-DHA radical and NO (20) . Because this reaction with Asc is unique to SNO among Cys oxidation products, it confers specificity to the BST. Our experimental evidence strongly supports this conclusion.
Our efforts to investigate the reports of false-positive biotinylation (9 -12), which we had not previously observed even at high Asc concentrations (8, 17) , revealed that indirect sunlight is the likely cause. The semi-DHAsc radical, an intermediate in the oxidation of Asc to DHAsc by sunlight, probably plays a role. Though semi-DHAsc cannot drive the single e Ϫ reduction of biological Cys disulfides (Cys disulfide radical/disulfide E red is ϳϪ1500 mV) (42) , it has been shown to reduce reactive synthetic disulfides such as 4,4Ј-dithiopyridine (23) , that are similar to biotin-HPDP. Indeed, we show that Asc in the presence of indirect sunlight reduces biotin-HPDP to biotin-SH, which would inevitably incorporate into protein disulfides to generate artifactual (i.e. SNO-independent) S-biotinylation, consistent with our findings and those of Huang et al. (12) .
Alternatively, the data might be explained by UV light-induced tryptophan photoexcitation, enabling the transfer of one e Ϫ to an adjacent disulfide to generate a disulfide radical (21, 22) , which transiently dissociates into free thiol plus thiyl radical. Thermodynamically, Asc should drive this reaction by further reducing Cys thiyl radical to thiol (Cys thiol/thiyl radical E red ϩ920 mV) (43) , which would then undergo biotinylation. Of relevance, Walmsley et al. (44) applied this rationale to explain their discovery that ambient daylight reduced 5,5Ј-dithiobis(2-nitrobenzoic acid) in the presence of Asc. Whatever the exact sequence of electron transfer that creates the artifact, we can recapitulate the result with indirect sunlight and Asc.
Interestingly, our experiments demonstrate that, even in the absence of Asc, indirect sunlight promotes the biotinylation of an SNO during the labeling step of the BST. Indirect sunlight likely contains sufficient UV light for SNO homolysis ( max 334 nm). Although it is generally thought that thiyl radicals proportionate to disulfides or are further oxidized, our experiments and those of others (21, 22) suggest that protein Cys thiyl radicals are, at least in small part, reduced to thiols that can subsequently react with biotin-HPDP. That Asc potentiates the effects of indirect sunlight on SNO biotinylation would be consistent with Asc-mediated reduction of thiyl radical (as described previously). Alternatively, the semi-DHAsc radical (semi-DHAsc/DHAsc E red Ϫ174 mV) (41) may directly reduce an SNO to thiol (they have similar reduction potentials; see above). Increased sensitivity of the BST as a result of sunlight, however, comes at the expense of specificity; the labeling step should therefore be performed under fluorescent light or in the dark.
A number of anti-cancer agents employed in clinical practice create an oxidative stress. Assessment of protein oxidation versus S-nitrosylation under these conditions has been a challenge. The introduction of the BST coupled to SNO photolysis has allowed us to rigorously demonstrate that pharmacologically induced oxidative stress in fact promotes GAPDH S-nitrosylation. Mechanisms for this increase in SNO-GAPDH may include a loss of reduced cellular GSH or oxidation of proteins necessary for the break down of S-nitrosothiols. Given the well established role of SNO-GAPDH in mediating cellular death (3, 37, 45) , our data raise the idea that clinically employed cancer chemotherapies (e.g. BCNU) may execute their functions via S-nitrosylation of specific cytotoxic effectors (e.g. SNO-GAPDH).
Unlike previous studies that have induced oxidative stresses by inhibition of GSH synthesis, we demonstrate that GSSG reductase-dependent recycling of GSSG to GSH plays a role in protein S-nitrosylation. GSH will accept NO from protein SNOs to generate GSNO, which can then be metabolized by GSNO reductase (46, 47) . The mechanism by which BCNU increases SNO-GAPDH most likely involves a relative depletion of reduced GSH (via GSSG reductase inhibition), thus abrogating the transnitrosylative pathways that generate GSNO. In identifying GSSG reductase as a regulatory component in SNO homeostasis, we established that oxidative stimuli may elicit their effects through S-nitrosylation rather than exclusively by Cys oxidation.
Notwithstanding the reproducibility and specificity of the BST for the detection of SNO proteins, we show here that SNO photolysis prior to the assay may be useful as a separate control. Whereas Asc generates an SNO-dependent signal, photolysis eliminates it. Photolysis may thus find wide application in instances where the BST does not respond to NOS agonists or inhibitors (which increase or eliminate endogenous SNO signals) or under conditions of diverse redox stresses (e.g. BCNU). The BST (when performed protected from sunlight) combined with SNO photolysis should provide a highly specific method for future investigations of S-nitrosylation, particularly under conditions that require differentiation of SNOs from other Cysbased modifications.
